These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 25098287

  • 1. Biochemical signaling of PD-1 on T cells and its functional implications.
    Boussiotis VA, Chatterjee P, Li L.
    Cancer J; 2014; 20(4):265-71. PubMed ID: 25098287
    [Abstract] [Full Text] [Related]

  • 2. The PD-1/PD-Ls pathway and autoimmune diseases.
    Dai S, Jia R, Zhang X, Fang Q, Huang L.
    Cell Immunol; 2014 Jul; 290(1):72-9. PubMed ID: 24908630
    [Abstract] [Full Text] [Related]

  • 3. The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation.
    Bardhan K, Anagnostou T, Boussiotis VA.
    Front Immunol; 2016 Jul; 7():550. PubMed ID: 28018338
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. PD-1, gender, and autoimmunity.
    Dinesh RK, Hahn BH, Singh RP.
    Autoimmun Rev; 2010 Jun; 9(8):583-7. PubMed ID: 20433954
    [Abstract] [Full Text] [Related]

  • 6. PD-1 as an immune modulatory receptor.
    Yao S, Chen L.
    Cancer J; 2014 Jun; 20(4):262-4. PubMed ID: 25098286
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. An optimized protocol for the in vitro generation and functional analysis of human PD1/PD-L1 signal.
    Khedri M, Abnous K, Rafatpanah H, Ramezani M.
    J Recept Signal Transduct Res; 2018 Feb; 38(1):31-36. PubMed ID: 29252078
    [Abstract] [Full Text] [Related]

  • 10. The programmed death-1 immune-suppressive pathway: barrier to antitumor immunity.
    Ostrand-Rosenberg S, Horn LA, Haile ST.
    J Immunol; 2014 Oct 15; 193(8):3835-41. PubMed ID: 25281753
    [Abstract] [Full Text] [Related]

  • 11. PD-1 signaling pathway in sepsis: Does it have a future?
    Chen R, Zhou L.
    Clin Immunol; 2021 Aug 15; 229():108742. PubMed ID: 33905818
    [Abstract] [Full Text] [Related]

  • 12. [Programmed cell death protein 1 and its ligands regulate immune balance in allergic rhinitis].
    Wen SL, Li F, Zhao F, Zuo JJ, Deng YQ, Zhang W, Tao ZZ.
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Apr 07; 55(4):384-390. PubMed ID: 32306637
    [Abstract] [Full Text] [Related]

  • 13. Tissue expression of PD-L1 mediates peripheral T cell tolerance.
    Keir ME, Liang SC, Guleria I, Latchman YE, Qipo A, Albacker LA, Koulmanda M, Freeman GJ, Sayegh MH, Sharpe AH.
    J Exp Med; 2006 Apr 17; 203(4):883-95. PubMed ID: 16606670
    [Abstract] [Full Text] [Related]

  • 14. B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance.
    Park JJ, Omiya R, Matsumura Y, Sakoda Y, Kuramasu A, Augustine MM, Yao S, Tsushima F, Narazaki H, Anand S, Liu Y, Strome SE, Chen L, Tamada K.
    Blood; 2010 Aug 26; 116(8):1291-8. PubMed ID: 20472828
    [Abstract] [Full Text] [Related]

  • 15. PD-L1 engagement on T cells promotes self-tolerance and suppression of neighboring macrophages and effector T cells in cancer.
    Diskin B, Adam S, Cassini MF, Sanchez G, Liria M, Aykut B, Buttar C, Li E, Sundberg B, Salas RD, Chen R, Wang J, Kim M, Farooq MS, Nguy S, Fedele C, Tang KH, Chen T, Wang W, Hundeyin M, Rossi JAK, Kurz E, Haq MIU, Karlen J, Kruger E, Sekendiz Z, Wu D, Shadaloey SAA, Baptiste G, Werba G, Selvaraj S, Loomis C, Wong KK, Leinwand J, Miller G.
    Nat Immunol; 2020 Apr 26; 21(4):442-454. PubMed ID: 32152508
    [Abstract] [Full Text] [Related]

  • 16. The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies.
    Shi L, Chen S, Yang L, Li Y.
    J Hematol Oncol; 2013 Sep 30; 6(1):74. PubMed ID: 24283718
    [Abstract] [Full Text] [Related]

  • 17. CD279 mediates the homeostasis and survival of regulatory T cells by enhancing T cell and macrophage interactions.
    Liu Y, Gao Y, Hao H, Hou T.
    FEBS Open Bio; 2020 Jun 30; 10(6):1162-1170. PubMed ID: 32324337
    [Abstract] [Full Text] [Related]

  • 18. Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape.
    Jiang X, Wang J, Deng X, Xiong F, Ge J, Xiang B, Wu X, Ma J, Zhou M, Li X, Li Y, Li G, Xiong W, Guo C, Zeng Z.
    Mol Cancer; 2019 Jan 15; 18(1):10. PubMed ID: 30646912
    [Abstract] [Full Text] [Related]

  • 19. The role of the PD-1 pathway in autoimmunity and peripheral tolerance.
    Fife BT, Pauken KE.
    Ann N Y Acad Sci; 2011 Jan 15; 1217():45-59. PubMed ID: 21276005
    [Abstract] [Full Text] [Related]

  • 20. Negative regulation of T-cell function by PD-1.
    Zha Yy, Blank C, Gajewski TF.
    Crit Rev Immunol; 2004 Jan 15; 24(4):229-37. PubMed ID: 15588223
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.